A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD

Thorax

Volumn 72, Issue 10, 2017, Pages 919-927

  Wilkinson, Tom M A ^a,b   Aris, Emmanuel ^c   Bourne, Simon ^a,d   Clarke, Stuart C ^a   Peeters, Mathieu ^c,e   Pascal, Thierry G ^c   Schoonbroodt, Sonia ^c   Tuck, Andrew C ^a   Kim, Viktoriya ^a,b   Ostridge, Kristoffer ^a,b   Staples, Karl J ^a   Williams, Nicholas ^a,b   Williams, Anthony ^a   Wootton, Stephen ^f   Devaster, Jeanne Marie ^c  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^c GSK   (Belgium)

^d QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

^e ThromboGenics NV   (Belgium)

^f UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Bacterial Infection; COPD Exacerbations; Respiratory Infection; Viral infection

Indexed keywords

ADULT; AGED; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MORAXELLA CATARRHALIS; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RHINOVIRUS; SEASON; SPUTUM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AIR MICROBIOLOGY; FEMALE; HAEMOPHILUS INFLUENZAE; HUMANS; MALE; MIDDLE AGED; MORAXELLA (BRANHAMELLA) CATARRHALIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RHINOVIRUS; SEASONS; SPUTUM;

EID: 85021648968     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2016-209023     Document Type: Article

References (36)

1. Jenkins CR, Celli B, Anderson JA, et al. Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study. Eur Respir J 2012;39:38-45.
2. Rabe KF, Fabbri LM, Vogelmeier C, et al. Seasonal distribution of COPD exacerbations in the Prevention of Exacerbations with Tiotropium in COPD trial. Chest 2013;143:711-19.
3. Donaldson GC, Wedzicha JA. The causes and consequences of seasonal variation in COPD exacerbations. Int J Chron Obstruct Pulmon Dis 2014;9:1101-10.
4. Garcha DS, Thurston SJ, Patel AR, et al. Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD. Thorax 2012;67:1075-80.
5. Huang YJ, Sethi S, Murphy T, et al. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease. J Clin Microbiol 2014;52:2813-23.
6. Wilkinson TM, Hurst JR, Perera WR, et al. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD. Chest 2006;129:317-24.
7. Papi A, Bellettato CM, Braccioni F, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006;173:1114-21.
8. Bourne S, Cohet C, Kim V, et al. Acute Exacerbation and Respiratory InfectionS in COPD (AERIS): protocol for a prospective, observational cohort study. BMJ Open 2014;4:e004546.
9. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-65.
10. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;363:1128-38.
11. Bertens LC, Reitsma JB, Moons KG, et al. Development and validation of a model to predict the risk of exacerbations in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2013;8:493-9.
12. Müllerová H, Shukla A, Hawkins A, et al. Risk factors for acute exacerbations of COPD in a primary care population: A retrospective observational cohort study. BMJ Open 2014;4:e006171.
13. Kerkhof M, Freeman D, Jones R, et al. Predicting frequent COPD exacerbations using primary care data. Int J Chron Obstruct Pulmon Dis 2015;10:2439-50.
14. Bafadhel M, Haldar K, Barker B, et al. Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function. Int J Chron Obstruct Pulmon Dis 2015;10:1075-83.
15. Barker BL, Haldar K, Patel H, et al. Association between pathogens detected using quantitative polymerase chain reaction with airway inflammation in COPD at stable state and exacerbations. Chest 2015;147:46-55.
16. Sethi S. Infection as a comorbidity of COPD. Eur Respir J 2010;35:1209-15.
17. Wang H, Gu X, Weng Y, et al. Quantitative analysis of pathogens in the lower respiratory tract of patients with chronic obstructive pulmonary disease. BMC Pulm Med 2015;15:94.
18. Molyneaux PL, Mallia P, Cox MJ, et al. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;188:1224-31.
19. Millares L, Ferrari R, Gallego M, et al. Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis 2014;33:1101-11.
20. Carvalho MGS, Tondella ML, McCaustland K, et al. Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA. J Clin Microbiol 2007;45:2460-6.
21. Zwaans WA, Mallia P, van Winden ME, et al. The relevance of respiratory viral infections in the exacerbations of chronic obstructive pulmonary disease-A systematic review. J Clin Virol 2014;61:181-8.
22. George SN, Garcha DS, Mackay AJ, et al. Human rhinovirus infection during naturally occurring COPD exacerbations. Eur Respir J 2014;44:87-96.
23. Clark TW, Medina MJ, Batham S, et al. C-reactive protein level and microbial aetiology in patients hospitalised with acute exacerbation of COPD. Eur Respir J 2015;45:76-86.
24. MacDonald M, Korman T, King P, et al. Exacerbation phenotyping in chronic obstructive pulmonary disease. Respirology 2013;18:1280-1.
25. Dai MY, Qiao JP, Xu YH, et al. Respiratory infectious phenotypes in acute exacerbation of COPD: an aid to length of stay and COPD Assessment Test. Int J Chron Obstruct Pulmon Dis 2015;10:2257-63.
26. Murphy TF, Parameswaran GI. Moraxella catarrhalis, a human respiratory tract pathogen. Clin Infect Dis 2009;49:124-31.
27. Mallia P, Footitt J, Sotero R, et al. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;186:1117-24.
28. Ohrui T, Yamaya M, Sekizawa K, et al. Effects of rhinovirus infection on hydrogen peroxide-induced alterations of barrier function in the cultured human tracheal epithelium. Am J Respir Crit Care Med 1998;158:241-8.
29. Oliver BG, Lim S, Wark P, et al. Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages. Thorax 2008;63:519-25.
30. Segal LN, Rom WN, Weiden MD. Lung microbiome for clinicians. New discoveries about bugs in healthy and diseased lungs. Ann Am Thorac Soc 2014;11:108-16.
31. Gulraiz F, Bellinghausen C, Bruggeman CA, et al. Haemophilus influenzae increases the susceptibility and inflammatory response of airway epithelial cells to viral infections. FASEB J 2015;29:849-58.
32. Bellinghausen C, Gulraiz F, Heinzmann AC, et al. Exposure to common respiratory bacteria alters the airway epithelial response to subsequent viral infection. Respir Res 2016;17:68.
33. Heinrich A, Haarmann H, Zahradnik S, et al. Moraxella catarrhalis decreases antiviral innate immune responses by down-regulation of TLR3 via inhibition of p53 in human bronchial epithelial cells. FASEB J 2016;30:2426-34.
34. Sethi S, Evans N, Grant BJ, et al. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002;347:465-71.
35. Desai H, Eschberger K, Wrona C, et al. Bacterial colonization increases daily symptoms in patients with chronic obstructive pulmonary disease. Ann Am Thorac Soc 2014;11:303-9.
36. Sethi S, Sethi R, Eschberger K, et al. Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;176:356-61